Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study

Fig. 2

Urine pH categories and UACR changes. A Proportion of patients with pH < 5.5 or ≥ 5.5 at baseline. B Proportion of patients with pH < 5.5, 5.5–6.2, or > 6.2 at week 12. C UACR at baseline and week 12. TaCCi mixture, tart cherry supplementary citrate mixture group; UACR, 24-h urinary albumin-creatinine ratio

Back to article page